The RANTES -403G > A promoter polymorphism in Korean men: Association with serum RANTES concentration and coronary artery disease

Clinical Science

Volumn 113, Issue 7-8, 2007, Pages 349-356

  Jang, Yangsoo ^a,b,c   Chae, Jey Sook ^c   Hyun, Yae Jung ^c   Koh, Soo Jeong ^c   Kim, Ji Young ^c   Ko, Min Ji ^c   Rim, Se Joong ^b   Shin, Hyun Joon ^b   Ordovas, Jose M ^d   Lee, Jong Ho ^c  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Yonsei University   (South Korea)

^d TUFTS UNIVERSITY   (United States)

Author keywords

403G > A polymorphism; Coronary artery disease (CAD); Myocardial infarction; Normal T cell expressed and secreted (RANTES); Regulated upon activation; Single nucleotide polymorphism; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; C REACTIVE PROTEIN; GLUCOSE; INSULIN; LIPID; RANTES; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ANGIOGRAPHY; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONCENTRATION (PARAMETERS); CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; INSULIN BLOOD LEVEL; KOREA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; THROMBOCYTE COUNT; ANTHROPOMETRY; BLOOD; BLOOD PRESSURE; CORONARY ARTERY ATHEROSCLEROSIS; DIABETIC ANGIOPATHY; GENETICS; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; AGED; ANTHROPOMETRY; BLOOD PRESSURE; C-REACTIVE PROTEIN; CORONARY ARTERIOSCLEROSIS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; GENE FREQUENCY; GENOTYPE; HUMANS; LIPIDS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET COUNT; POLYMORPHISM, SINGLE NUCLEOTIDE; RANTES;

EID: 34648835376     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20070014     Document Type: Article

References (27)

1. Libby, P. (2002) Inflammation in atherosclerosis. Nature 420, 868-874
2. Cocchi, F., Devico, A. L., Garzino-Demo, A., Arya, S. K., Gallo, R. C. and Lusso, P. (1995) Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 270, 1811-1815
3. Veillard, N. R., Kwak, B., Pelli, G. et al. (2004) Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice. Circ. Res. 94, 253-261
4. An, P., Nelson, G. W., Wang, L. et al. (2002) Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proc. Natl. Acad. Sci. U.S.A. 99, 10002-10007
5. Nickel, R. G., Casolaro, V., Wahn, U. et al. (2000) Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J. Immunol. 164, 1612-1616
6. McDermott, D. H., Beecroft, M. J., Kleeberger, C. A. et al. (2000) Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study. AIDS 14, 2671-2678
7. Simeoni, E., Winkelmann, B. R., Hoffmann, M. M. et al. (2004) Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis. Eur. Heart J. 25, 1438-1446
8. Waehre, T., Damas, J. K., Gullestad, L. et al. (2003) Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease. J. Am. Coll. Cardiol. 41, 1460-1467
9. Hansson, G. K. (2001) Immune mechanisms in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 21, 1876-1890
10. Stemme, S., Faber, B., Holm, J., Wiklund, O., Witztum, J. L. and Hansson, G. K. (1995) T lymphocytes from human atherosclerotic plaques recognize oxidized low-density lipoprotein. Proc. Natl. Acad. Sci. U.S.A. 92, 3893-3897
11. Makino, Y., Cook, D. N., Smithies, O. et al. (2002) Impaired T cell function in RANTES-deficient mice. Clin. Immunol. 102, 302-309
12. Von Hundelshausen, P., Weber, K. S. C., Huo, Y. et al. (2005) RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 103, 1772-1777
13. Weyrich, A. S., Elstad, M. R., McEver, R. P. et al. (1996) Activated platelets signal chemokine synthesis by human monocytes. J. Clin. Invest. 97, 1525-1534
14. Horuk, R., Clayberger, C., Krensky, A. M. et al. (2001) A non-peptide functional antagonist of the CCR1 chemokine receptor is effective in rat heart transplant rejection. J. Biol. Chem. 276, 4199-4204
15. Strizki, J. M., Xu, S., Wagner, N. E., Wojcik, L. et al. (2001) SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 98, 12718-12723
16. Fryer, A. A., Spiteri, M. A., Bianco, A. et al. (2000) The -403 G > A promoter polymorphism in the RANTES gene is associated with atopy and asthma. Genes Immun. 1, 509-514
17. Takada, T., Suzuki, E., Ishida, T. et al. (2001) Polymorphism in RANTES chemokine promoter affects extent of sarcoidosis in Japanese. Tissue Antigens 58, 293-298
18. Szalai, C., Duba, J., Prohaszka, Z. et al. (2001) Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD): coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis 158, 233-239
19. Zhernakova, A., Alizadeh, B. Z., Eerligh, P. et al. (2006) Genetic variants of RANTES are associated with serum RANTES level and protection for type 1 diabetes. Genes Immun. 7, 544-549
20. Boger, C. A., Fischereder, M., Deinzer, M. et al. (2005) RANTES gene polymorphisms predict all-cause and cardiac mortality in Type 2 diabetes mellitus hemodialysis patients. Atherosclerosis 183, 121-129
21. Sabeti, P. C., Schaffner, S. F., Fry, B. et al. (2006) Positive natural selection in the human lineage. Science 312, 1614-1620
22. Marenberg, M. E., Risch, N., Berkman, L. F., Floderus, B. and de Faire, U. (1994) Genetic susceptibility to death from coronary heart disease in a study of twins. N. Eng. J. Med. 330, 1041-1046
23. Satriano, J. A., Banas, B., Luckow, B., Nelson, P., Krensky, A. M. and Schlondorff, D. O. (1997) Regulation of RANTES and ICAM-1 expression in murine mesangial cells. J. Am. Soc. Nephrol. 8, 596-603
24. Schwarz, M., Radeke, H. H., Resch, K. and Uciechowski, P. (1997) Lymphocyte-derived cytokines induce sequential expression of mono-human mesangial cells. Kidney Int. 52, 1521-1531
25. Weyrich, A. S., Prescott, S. M. and Zimmermann, G. A. (2002) Platelets, endothelial cells, inflammatory chemokines, and restenosis. Circulation 106, 1433-1435
26. Locati, M., Deuschle, U., Massardi, M. L. et al. (2002) Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes. J. Immunol. 168, 3557-3562
27. Gallo, R. C., Garzino-Demo, A. and DeVico, A. L. (1999) HIV infection and pathogenesis: what about chemokines? J. Clin. Immunol. 19, 293-299